Overview Financials News + Filings Key Docs Charts Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
CC transcript
Appointed director
Inv. presentation
Quarterly results
Appointed COO
|
|
TIANYIN PHARMACEUTICAL CO., INC. (TPI)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 01/11/2016 |
8-K/A
| Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Financial Statements and...|
Docs:
|
"TPI Received Acceptance Letter From NYSE MKT Regarding its Plan of Compliance with Continued Listing Requirements Tianyin Pharmaceutical Inc. , a pharmaceutical company that specializes in the patented biopharmaceutical, modernized traditional Chinese medicine , branded generics and active pharmaceutical ingredients , received a plan acceptance letter on January 5, 2016 from the NYSE MKT LLC indicating that the Exchange accepted the Company’ s compliance plan, submitted on October 19, 2015 and supplemented on December 4, 2015, regarding the Company’ s non-compliance of certain of the Exchange’ s continued listing standards, as set forth in Sections 134 and 1101 of the NYSE MKT Company Guide. The Company was notified by the Exchange previously of its noncompliance of the continued listing s..." |
|
| 12/23/2015 |
8-K/A
| Other Events |
| 02/06/2015 |
8-K/A
| Other Events, Financial Statements and Exhibits |
| 10/27/2014 |
8-K/A
| Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements... |
| 07/08/2014 |
8-K/A
| Other Events |
| 06/23/2014 |
8-K/A
| Other Events |
| 05/14/2014 |
8-K/A
| Other Events |
| 10/15/2013 |
8-K/A
| Changes in Registrant's Certifying Accountant, Financial Statements and Exhibits |
| 07/07/2011 |
8-K/A
| Form 8-K/A - Current report [Amend] |
| 02/14/2008 |
8-K/A
| Form 8-K/A - Current report [Amend] |
|
|